A smartphone test for detecting heart disease biomarkers.
Plasmonically Enhanced Point-of-care Detection of Cardiac Biomarkers by a Smart Phone
This study is working on a new, simple test that lets you check important heart health markers using just a drop of blood and your smartphone, making it easy to use at home or in a hospital for people with heart conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10570910 on NIH RePORTER |
What this research studies
This research aims to develop a new, easy-to-use test that can quickly measure important heart disease biomarkers using a smartphone. By combining advanced printing technology and special nanostructures, the test will allow for the detection of multiple biomarkers from just a drop of blood, making it suitable for use in both hospitals and at home. The biomarkers being targeted are crucial for diagnosing and managing various cardiovascular conditions, including heart attacks and heart failure. This innovative approach seeks to provide rapid and accurate results, improving patient care and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing symptoms of heart disease or those at risk for cardiovascular conditions.
Not a fit: Patients with non-cardiovascular conditions or those who do not have access to the necessary smartphone technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accessible heart disease diagnosis and management for patients.
How similar studies have performed: Previous research has shown promise in using similar technologies for point-of-care testing, indicating potential success for this innovative approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Mikkelsen, Maiken — Duke University
- Study coordinator: Mikkelsen, Maiken
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.